# Alprazolam

## Xanax 0.5mg

| TAH Drug Code      | [OXAN](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OXAN)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Anxiety state.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Dosing             | Adults: General dose: 0.25-0.5mg TID， dosage range:0.5-4mg/day. Slowly reduce the dose when stopping the drug. The reduction should not exceed 0.5mg every three days. Elderly or frail patients: Elderly patients who have not used psychotropic drugs should be treated with the lowest effective dose. Children: Safety and efficacy have not been established.                                                                                                                                                                                                                                                                          |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Contraindications  | Acute narrow angle glaucoma. Concomitant use with strong CYP3A inhibitors， except ritonavir. Hypersensitivity to benzodiazepines.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Adverse Effects    | Common: Decrease in appetite (7.3-27.8%)， Increased appetite (7-32.7%)， Weight increased (2.7-27.2%)， Constipation (8.1-26.2%)， Reduced salivation (32.8%)， Xerostomia (10.2-14.7%)， Cognitive disorder (28.8%)， Confusion (1.5-10.4%)， Dysarthria (10.9-23.3%)， Incoordination (9.4-40.1%)， Lightheadedness (20.8%)， Memory impairment (15.4-33.1%)， Sedated (45.2%)， Somnolence (23-76.8%)， Irritability (immediate-release， 33.1%; extended-release 1% or more)， Reduced libido (6-14.4%)， Fatigue (13.9-48.6%) Serious: Stevens-Johnson syndrome， Liver failure， Seizure co-occurrent and due to substance withdrawal |
| Pregnancy          | Human (and Animal) Data Suggest Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| More Info          | [UpToDate](https://www.uptodate.com/contents/alprazolam-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |

